AskNiveshLive·14:08 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to PPLPHARMA

Piramal Pharma Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
2,7541,9342,0442,1402,752
Other income
4258664346
Expenses
2,5402,1102,1702,2462,593
Cost of materials consumed
204524483505483
Purchases of stock-in-trade
547343375377336
Change in inventories
205-173-156-96237
Employee benefit expense
612619611600586
Finance costs
10486828983
Depreciation & amortisation
243197203213218
Other expenses
626514571558650
EBITDA
604186224198330
EBIT
361-1121-15112
Exceptional items
-21--41-176
Profit Before Tax
257-98-61-10429
Tax expense
1193534252
Deferred tax
26-32-2-526
Net Profit
154-82-99-136-9
Financial Ratios
Operating Profit Margin
13.11%-0.59%1.05%-0.69%4.08%
EBITDA Margin
21.93%9.60%10.98%9.26%12.01%
Net Profit Margin
5.59%-4.22%-4.85%-6.36%-0.32%
Earnings Per Share (₹)
1.16-0.62-0.75-1.03-0.07

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.